Holzman, David <br/><br/>
Has success spoiled hairy cell leukemia research? Key questions go unanswered, despite big gains.  [electronic resource] 

 -  Journal of the National Cancer Institute  Mar 2009 
 - 370-3 p.  digital 
<br/><br/> Publication Type: Historical Article; News 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djp051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--adverse effects<br/>Biomedical Research--history<br/>Bone Marrow--drug effects<br/>Cell Proliferation--drug effects<br/>Cladribine--pharmacology<br/>History, 20th Century<br/>History, 21st Century<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Interferons--pharmacology<br/>Leukemia, Hairy Cell--drug therapy<br/>Leukocyte Count<br/>Leukocytes--drug effects<br/>Nucleosides--adverse effects<br/>Pentostatin--pharmacology<br/>Rituximab<br/>Workforce